Rosenberg, Carla 
; Navajas, L; Vagenas, Dulci Fonseca; Bakker, E; Vainzof, Mariz ; Passos-Bueno, Maria Rita ; Takata, R I; Van Ommen, G J B; Zatz, Mayana ; Den Dunnen, J T
Fonte: Neuromuscular Disorders. Unidade: IB
Assunto: GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSENBERG, Carla et al. Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization. Neuromuscular Disorders, v. 8, p. 417-452, 1998Tradução . . Disponível em: https://doi.org/10.1016/s0960-8966(98)00050-9. Acesso em: 13 out. 2025.APA
Rosenberg, C., Navajas, L., Vagenas, D. F., Bakker, E., Vainzof, M., Passos-Bueno, M. R., et al. (1998). Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization. Neuromuscular Disorders, 8, 417-452. doi:10.1016/s0960-8966(98)00050-9NLM
Rosenberg C, Navajas L, Vagenas DF, Bakker E, Vainzof M, Passos-Bueno MR, Takata RI, Van Ommen GJB, Zatz M, Den Dunnen JT. Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization [Internet]. Neuromuscular Disorders. 1998 ; 8 417-452.[citado 2025 out. 13 ] Available from: https://doi.org/10.1016/s0960-8966(98)00050-9Vancouver
Rosenberg C, Navajas L, Vagenas DF, Bakker E, Vainzof M, Passos-Bueno MR, Takata RI, Van Ommen GJB, Zatz M, Den Dunnen JT. Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization [Internet]. Neuromuscular Disorders. 1998 ; 8 417-452.[citado 2025 out. 13 ] Available from: https://doi.org/10.1016/s0960-8966(98)00050-9
